GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling
Authors
Keywords
-
Journal
PROSTATE
Volume 78, Issue 3, Pages 166-177
Publisher
Wiley
Online
2017-11-28
DOI
10.1002/pros.23461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis
- (2016) Qing-Hai Ye et al. CANCER CELL
- Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion
- (2015) Anne-Marie Byrne et al. BRITISH JOURNAL OF CANCER
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
- (2015) Theodoros Karantanos et al. EUROPEAN UROLOGY
- Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer
- (2015) Kosj Yamoah et al. JOURNAL OF CLINICAL ONCOLOGY
- Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion
- (2015) Di Jin et al. Oncotarget
- Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer
- (2015) Sooryanarayana Varambally et al. NEOPLASIA
- Prevention and early detection of prostate cancer
- (2014) Jack Cuzick et al. LANCET ONCOLOGY
- SnapShot: Prostate Cancer
- (2013) LaMont J. Barlow et al. CANCER CELL
- Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
- (2013) Rhonda L Bitting et al. ENDOCRINE-RELATED CANCER
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- The Golgi in Cell Migration: Regulation by Signal Transduction and Its Implications for Cancer Cell Metastasis
- (2012) Valentina Millarte et al. TheScientificWorldJOURNAL
- Diagnostic Significance of Overexpression of Golgi Membrane Protein 1 in Prostate Cancer
- (2012) Wenzhi Li et al. UROLOGY
- Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
- (2011) Matthew T. Burger et al. ACS Medicinal Chemistry Letters
- Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
- (2010) Yilei Mao et al. GUT
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease
- (2010) Becky Inkster et al. NEUROBIOLOGY OF AGING
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
- (2010) L. Furic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases
- (2009) Jasmine V. Abella et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Hepatocyte GP73 expression in Wilson disease
- (2009) Lorinda M. Wright et al. JOURNAL OF HEPATOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus
- (2008) Shuanzeng Wei et al. PROSTATE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now